The Great Brain Drain

In life sciences it can seem as though new regulations are being announced or coming into force every few weeks. On top of the authorities’ need to safeguard patients, consumers expect more transparency – about a product’s contents, origins and processes. All of this is creating more red tape for the industry: requirements that need to be serviced and managed.

The more rules there are, and the more frequently these change, the greater the risk of something going wrong. Similarly the more products, variants and markets a company is dealing with, and the shorter the release cycles, the greater the controls needed across documentation, packaging and labelling to ensure nothing slips through the cracks.

This article is taken from International Pharmaceutical Industry Magazine, July 2016